Caricamento...

Immune checkpoint inhibitors in genitourinary malignancies

Although immune-mediated therapies have been used in genitourinary (gu) malignancies for decades, recent advances with monoclonal antibody checkpoint inhibitors (cpis) have led to a number of promising treatment options. In renal cell carcinoma (rcc), cpis have been shown to have benefit over conven...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Oncol
Autori principali: Thana, M., Wood, L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Multimed Inc. 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194001/
https://ncbi.nlm.nih.gov/pubmed/32368176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5121
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !